IE
RVPH

Israel Englander’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History

Israel Englander’s Portfolio RVPH Stock Details RVPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-793,948
Closed -$579K – 6335
2026
Q1 		$579K Buy
793,948
+680,774
+602% +$3.1M ﹤0.01% 4688
2025
Q4 		$632K Buy
113,174
+27,613
+32% +$307K ﹤0.01% 4796
2025
Q3 		$631K Buy
85,561
+11,159
+15% +$94.8K ﹤0.01% 4934
2025
Q2 		$567K Sell
74,402
-2,314
-3% -$36K ﹤0.01% 4818
2025
Q1 		$1.46M Sell
76,716
-13,508
-15% -$425K ﹤0.01% 4069
2024
Q4 		$3.27M Sell
90,224
-1,417
-2% -$39.5K ﹤0.01% 3215
2024
Q3 		$2.64M Buy
91,641
+29,566
+48% +$657K ﹤0.01% 3442
2024
Q2 		$1.59M Buy
62,075
+19,345
+45% +$879K ﹤0.01% 3732
2024
Q1 		$3.23M Buy
42,730
+2,635
+7% +$209K ﹤0.01% 3298
2023
Q4 		$4.13M Buy
40,095
+18,938
+90% +$1.7M ﹤0.01% 2947
2023
Q3 		$2.06M Sell
21,157
-1,827
-8% -$170K ﹤0.01% 3522
2023
Q2 		$2.69M Buy
22,984
+21,062
+1,096% +$2.67M ﹤0.01% 3218
2023
Q1 		$161K Buy
+1,922
New +$168K ﹤0.01% 5260
2021
Q2 		– Sell
-1,766
Closed -$203K – 7030
2021
Q1 		$203K Buy
+1,766
New +$295K ﹤0.01% 5491

Other funds holding RVPH

ECM
EMC Capital Management Houston, Texas $253M AUM
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
PUI
Purpose Unlimited Inc Toronto $2.62B AUM
MGI
Miller Global Investments Dallas, Texas $121M AUM
MWM
Mosley Wealth Management Anaheim, California $314M AUM

Israel Englander's RVPH Position: Q2 2026 in Review

Israel Englander sold out of REVIVA PHARMA HLDGS INC (RVPH) in Q2 2026, closing a stake of 793,948 shares — an estimated $579K sold.

Israel Englander first reported a position in RVPH in Q1 2021 and held it in 14 quarters. The position peaked at $4.13M in Q4 2023. 5 funds tracked by Wall St. Rank hold RVPH as of Q2 2026.

  • Israel Englander reported no remaining REVIVA PHARMA HLDGS INC position as of Q2 2026 after selling out during the quarter.
  • Israel Englander sold 793,948 REVIVA PHARMA HLDGS INC shares in Q2 2026, an estimated $579K.
  • Israel Englander first reported a position in REVIVA PHARMA HLDGS INC in Q1 2021 and held it in 14 quarters.
  • Israel Englander's REVIVA PHARMA HLDGS INC position peaked at $4.13M in Q4 2023.
  • 5 funds tracked by Wall St. Rank held REVIVA PHARMA HLDGS INC as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.